Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the pricing of its “best efforts” ...
Shares of Amesite were down 15% to $3.45 in after-hours trading Monday following an announcement of a public offering. In a prospectus supplement, the company reiterated that there is substantial ...
CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced the pricing of a best-efforts publicoffering of 16,130,000 ...
today announced the pricing of its initial publicoffering of 1,750,000 ordinary shares at a publicoffering price of US$4.00 per share (the "Offering"). The underwriters will have a 45-day ...
Some results have been hidden because they may be inaccessible to you